Ideas for the decisions in front of you.
Our perspectives focus on the points where pharmaceutical strategy becomes operational: portfolio choices, market-entry dependencies, transfer governance, supply resilience, commercial readiness, and technology adoption.
Point of view
Useful insight should sharpen a choice—not merely describe a trend.
We write from the perspective of decision architecture: what leaders need to distinguish, what assumptions deserve pressure-testing, and what must become true for a strategic direction to work in practice.